{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:08Z","timestamp":1772166188975,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Polycythemia vera (PV) is characterized by red cell mass expansion in the peripheral blood and can be complicated with thrombosis, bleeding, evolution to acute myeloid leukemia (AML) or a fibrotic phase. Paroxysmal nocturnal hemoglobinuria (PNH) in an acquired clonal haematopoietic stem cell disorder associated with chronic intravascular hemolysis, venous thrombosis, defective hematopoiesis, frequent episodes of infection and, rarely, leukemic transformation. Herein, we report an interesting case of a patient with coexistence of PNH clones and a\n                      <jats:italic>JAK2V617F<\/jats:italic>\n                      positive PV, with unusual thromboses without hemolysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 51-year-old woman presented with increased levels of hematocrit, multiple liver, spleen, and left kidney infarctions and ascites; further investigation revealed a\n                      <jats:italic>JAK2V617F<\/jats:italic>\n                      -positive polycythemia vera and the presence of a significant PNH population (more than 90% CD55\u2013 CD59\u2013 cells among both granulocytes and red blood cells). Interestingly, the patient has experienced severe thrombotic events without any signs or symptoms of hemolysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case raises questions over uncharted aspects of the PNH etiopathogenesis and its potential association with myeloproliferative neoplasms (MPN) and highlights the difficulty of diagnosing and managing patients with more than one potentially thrombophilic conditions, especially with established and severe thromboses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12959-021-00269-8","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:04:04Z","timestamp":1615356244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature"],"prefix":"10.1186","volume":"19","author":[{"given":"Sevastianos","family":"Chatzidavid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nefeli","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis Theodorou","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Katsiampoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Lakiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stratigoula","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora-Athina","family":"Viniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Dryllis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"4","key":"269_CR1","first-page":"355","volume":"22","author":"JI Dickstein","year":"1995","unstructured":"Dickstein JI, Vardiman JW. Hematopathologic findings in the myeloproliferative disorders. Semin Oncol. 1995;22(4):355\u201373.","journal-title":"Semin Oncol"},{"issue":"2","key":"269_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","volume":"8","author":"T Barbui","year":"2018","unstructured":"Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15.","journal-title":"Blood Cancer J"},{"key":"269_CR3","doi-asserted-by":"publisher","unstructured":"Gaidano V, Geuna M, Cignetti A, Carnuccio F, Bernabei P, et al. Myeloproliferative neoplasms, thrombosis and paroxysmal nocturnal hemoglobinuria: Is this triad more frequent than we thought? Hematol Med Oncol. 2017;2. https:\/\/doi.org\/10.15761\/HMO.1000132.","DOI":"10.15761\/HMO.1000132"},{"key":"269_CR4","doi-asserted-by":"crossref","unstructured":"Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F, Randi ML, Vaidya R, Cazzola M, Rambaldi A, Gisslinger B, Pieri L, Ruggeri M, Bertozzi I, Sulai NH, Casetti I, Carobbio A, Jeryczynski G, Larson DR, M\u00fcllauer L, Pardanani A, Thiele J, Passamonti F, Barbui T. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013;27(9):1874-81.","DOI":"10.1038\/leu.2013.163"},{"issue":"1","key":"269_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1163\/15685590151092643","volume":"31","author":"J Meletis","year":"2001","unstructured":"Meletis J, Terpos E, Samarkos M, et al. Detection of CD55 and\/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. Haematologia (Budap). 2001;31(1):7\u201316.","journal-title":"Haematologia (Budap)"},{"key":"269_CR6","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill A, DeZern AE, Kinoshita T, Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028.","journal-title":"Nat Rev Dis Primers"},{"key":"269_CR7","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014;124:2804.","journal-title":"Blood"},{"issue":"1","key":"269_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.thj.6200077","volume":"2","author":"J Meletis","year":"2001","unstructured":"Meletis J, Terpos E, Samarkos M, Meletis C, Apostolidou E, Komninaka V, Korovesis K, Mavrogianni D, Boutsis D, Variami E, Viniou N, Konstantopoulos K, Loukopoulos D. Detection of CD55- and\/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes. Hematol J. 2001;2(1):33\u20137.","journal-title":"Hematol J"},{"key":"269_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1055\/s-0038-1657599","volume":"78","author":"R Landolfi","year":"1997","unstructured":"Landolfi R, Marchioli R, Patrono C. Mechanisms of bleeding and thrombosis in myeloproliferative disorders. Thromb Haemost. 1997;78:617.","journal-title":"Thromb Haemost"},{"key":"269_CR10","doi-asserted-by":"crossref","unstructured":"Pardanani A, Lasho TL, Hussein K, Schwager SM, Finke CM, Pruthi RK, Tefferi A. JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients. Mayo Clin Proc. 2008;83(4):457\u20139.","DOI":"10.4065\/83.4.457"},{"key":"269_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1538-7836.2007.02811.x","volume":"6","author":"V Ugo","year":"2008","unstructured":"Ugo V, Le Gal G, Lecucq L, et al. Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism. J Thromb Haemost. 2008;6:203.","journal-title":"J Thromb Haemost"},{"key":"269_CR12","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","volume":"113","author":"F Dentali","year":"2009","unstructured":"Dentali F, Squizzato A, Brivio L, et al. JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009;113:5617.","journal-title":"Blood"},{"key":"269_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1055\/s-2007-996117","volume":"23","author":"V De Stefano","year":"1997","unstructured":"De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost. 1997;23:411.","journal-title":"Semin Thromb Hemost"},{"key":"269_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","volume":"94","author":"D Valla","year":"1988","unstructured":"Valla D, Casadevall N, Huisse MG, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology. 1988;94:1063.","journal-title":"Gastroenterology"},{"key":"269_CR15","first-page":"981","volume":"76","author":"A Pagliuca","year":"1990","unstructured":"Pagliuca A, Mufti GJ, Janossa-Tahernia M, et al. In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative state. Q J Med. 1990;76:981.","journal-title":"Q J Med"},{"key":"269_CR16","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","volume":"120","author":"JH Smalberg","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, et al. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921.","journal-title":"Blood"},{"key":"269_CR17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/hep.21435","volume":"44","author":"M Primignani","year":"2006","unstructured":"Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528\u201334.","journal-title":"Hepatology"},{"issue":"8","key":"269_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/10245332.2018.1444563","volume":"23","author":"SI Kokoris","year":"2018","unstructured":"Kokoris SI, Gavriilaki E, Miari A, Travlou \u0391, Kyriakou E, Anagnostopoulos A, Grouzi E. Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment. Hematology. 2018;23(8):558\u201366.","journal-title":"Hematology"},{"issue":"6","key":"269_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/bjh.12461","volume":"162","author":"M Sekhar","year":"2013","unstructured":"Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol. 2013;162(6):730\u201347. https:\/\/doi.org\/10.1111\/bjh.12461.","journal-title":"Br J Haematol"},{"issue":"5","key":"269_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1600-0609.1995.tb00703.x","volume":"55","author":"J Acharya","year":"1995","unstructured":"Acharya J, Westwood NB, Sawyer BM, et al. Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol. 1995;55(5):315\u201321.","journal-title":"Eur J Haematol"},{"issue":"4","key":"269_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","volume":"129","author":"Y Chait","year":"2005","unstructured":"Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005;129(4):553\u201360. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05490.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"269_CR22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","volume":"130","author":"RK Patel","year":"2006","unstructured":"Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006;130(7):2031\u20138.","journal-title":"Gastroenterology"},{"issue":"9","key":"269_CR23","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1182\/blood-2006-05-021527","volume":"108","author":"M Boissinot","year":"2006","unstructured":"Boissinot M, Lippert E, Girodon F, et al. Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis. Blood. 2006;108(9):3223\u20134.","journal-title":"Blood"},{"issue":"1","key":"269_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1538-7836.2011.04562.x","volume":"10","author":"ST Van Bijnen","year":"2012","unstructured":"Van Bijnen ST, Van Heerde WL, Muus P. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost. 2012;10(1):1\u201310.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"269_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjh.13183","volume":"168","author":"C L\u2019Acqua","year":"2015","unstructured":"L\u2019Acqua C, Hod E. New perspectives on the thrombotic complications of haemolysis. Br J Haematol. 2015;168(2):175\u201385.","journal-title":"Br J Haematol"},{"issue":"5","key":"269_CR26","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI136094","volume":"130","author":"E Gavriilaki","year":"2020","unstructured":"Gavriilaki E, Brodsky RA. Complementopathies and precision medicine. J Clin Invest. 2020;130(5):2152\u201363.","journal-title":"J Clin Invest"},{"issue":"1","key":"269_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ejvs.2002.1778","volume":"25","author":"FJI Fowkes","year":"2003","unstructured":"Fowkes FJI, Price JF, Fowkes FGR. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg. 2003;25(1):1\u20135.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"269_CR28","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","volume":"102","author":"C Hall","year":"2003","unstructured":"Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587\u201391.","journal-title":"Blood"},{"issue":"3","key":"269_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2141.1997.d01-2047.x","volume":"96","author":"JY Jin","year":"1997","unstructured":"Jin JY, Tooze JA, Marsh JCW, Gordon-Smith EC. Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils. Br Soc Haematol. 1997;96(3):493\u20136.","journal-title":"Br Soc Haematol"},{"issue":"25","key":"269_CR30","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(25):4985\u20135105. https:\/\/doi.org\/10.1182\/blood-2012-09-311381.","journal-title":"Blood"},{"key":"269_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/blood.V36.4.428.428","volume":"36","author":"NE Hansen","year":"1970","unstructured":"Hansen NE, Killmann SA. Paroxysmal nocturnal hemoglobinuria in myelofibrosis. Blood. 1970;36:428\u201331.","journal-title":"Blood"},{"key":"269_CR32","first-page":"13","volume":"64","author":"L Luzzatto","year":"1979","unstructured":"Luzzatto L, Familusi JB, Williams CK, Junaid TA, Rotoli B, Alfinito F. The PNH abnormality in myeloproliferative disorders: association of PNH and acute erythremic myelosis in two children. Haematologica. 1979;64:13\u201330.","journal-title":"Haematologica"},{"key":"269_CR33","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253.","journal-title":"N Engl J Med"},{"key":"269_CR34","first-page":"805","volume":"14","author":"H Hirai","year":"1973","unstructured":"Hirai H, Asahara A, Suzuki R. A case of myelofibrosis with paroxysmal nocturnal hemoglobinuria. Rinsho Ketsueki. 1973;14:805\u201311.","journal-title":"Rinsho Ketsueki"},{"key":"269_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0002-9343(92)90201-L","volume":"93","author":"DL Graham","year":"1992","unstructured":"Graham DL, Gastineau DA. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. Am J Med. 1992;93:671\u20134.","journal-title":"Am J Med"},{"key":"269_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10428199309059582","volume":"12","author":"J Nakahata","year":"1993","unstructured":"Nakahata J, Takahashi M, Fuse I, et al. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia. Leuk Lymphoma. 1993;12:137\u201342.","journal-title":"Leuk Lymphoma"},{"key":"269_CR37","first-page":"181183","volume":"9","author":"AW Boyd","year":"1970","unstructured":"Boyd AW, Parkin JD, Castaldi PA. A case of paroxysmal nocturnal hemoglobinuria terminating in a myeloproliferative syndrome. Aust N Z J Med. 1970;9:181183.","journal-title":"Aust N Z J Med"},{"key":"269_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2141.1971.tb02715.x","volume":"31","author":"D Catovsky","year":"1971","unstructured":"Catovsky D, Lewis SM, Sherman D. Erythrocyte sensitivity to in vitro lysis in leukaemia. Br J Haematol. 1971;31:541\u201350.","journal-title":"Br J Haematol"},{"key":"269_CR39","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1038\/bcj.2012.7","volume":"2","author":"C Sugimori","year":"2012","unstructured":"Sugimori C, Padron E, Caceres G, et al. Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2012;2:e63.","journal-title":"Blood Cancer J"},{"key":"269_CR40","first-page":"107","volume":"7","author":"YS Fraiman","year":"2016","unstructured":"Fraiman YS, Cuka N, Batista D, Vuica-Ross M, Moliterno AR. Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm. J Blood Med. 2016;7:107\u201310.","journal-title":"J Blood Med"},{"key":"269_CR41","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/leu.2015.268","volume":"30","author":"R Tominaga","year":"2016","unstructured":"Tominaga R, Katagiri T, Kataoka K, et al. Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell. Leukemia. 2016;30:1208\u201310.","journal-title":"Leukemia"},{"issue":"12","key":"269_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.clml.2019.07.441","volume":"19","author":"O Gutwein","year":"2019","unstructured":"Gutwein O, Englander Y, Herzog-Tzarfati K, Filipovich-Rimon T, Apel A, Marcus R, Rahimi-Levene N, Koren-Michowitz M. Prevalence of paroxysmal nocturnal hemoglobinuria clones in myeloproliferative neoplasm patients: a cross-sectional study. Clin Lymphoma Myeloma Leuk. 2019;19(12):812\u20134.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"269_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1182\/blood.V40.6.875.875","volume":"40","author":"C-Y Kuo","year":"1972","unstructured":"Kuo C-Y, Van Voolen GA, Morrison AN. Primary and secondary myelofibrosis: its relationship to \u201cPNH-like\u201d defect. Blood. 1972;40(6):875\u201380.","journal-title":"Blood"},{"issue":"8","key":"269_CR44","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RR de Latour","year":"2008","unstructured":"de Latour RR, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099\u2013106.","journal-title":"Blood"},{"key":"269_CR45","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1172\/JCI74747","volume":"124","author":"W Shen","year":"2014","unstructured":"Shen W, Clemente MJ, Hosono N, Yoshida K, Przychodzen B, et al. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2014;124:4529\u201338.","journal-title":"J Clin Invest"},{"key":"269_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005;128:275\u201390.","journal-title":"Br J Haematol"},{"key":"269_CR47","doi-asserted-by":"publisher","first-page":"bcr2014205663","DOI":"10.1136\/bcr-2014-205663","volume":"2014","author":"C Jones","year":"2014","unstructured":"Jones C, Levy Y, Tong AW. Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome. BMJ Case Rep. 2014;2014:bcr2014205663 Published 2014 Dec 1.","journal-title":"BMJ Case Rep"},{"key":"269_CR48","first-page":"211","volume":"78","author":"MJ Borowitz","year":"2012","unstructured":"Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2012;78:211\u201330.","journal-title":"Cytometry B Clin Cytom"},{"key":"269_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/cyto.b.21023","volume":"82","author":"DR Sutherland","year":"2012","unstructured":"Sutherland DR, Keeney M, Illingworth A. Practical guidelines for the highsensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry B Clin Cytom. 2012;82:195\u2013208.","journal-title":"Cytometry B Clin Cytom"},{"issue":"25","key":"269_CR50","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(25):4985\u201396.","journal-title":"Blood"},{"issue":"10","key":"269_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ajh.21506","volume":"84","author":"A Emadi","year":"2009","unstructured":"Emadi A, Brodsky RA. Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria. Am J Hematol. 2009;84(10):699.","journal-title":"Am J Hematol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-021-00269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12959-021-00269-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-021-00269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T08:11:51Z","timestamp":1615363911000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-021-00269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1186\/s12959-021-00269-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-114657\/v1","asserted-by":"object"}]},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}